Jump Financial’s Ventyx Biosciences VTYX Stock Holding History

Jump Financial’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-76,200	Closed	-$688K	–	2451
2025 Q4	$688K	Buy	+76,200	New	+$569K	0.01%	1150
2025 Q3	–	Sell	-24,956	Closed	-$53.4K	–	2257
2025 Q2	$53.4K	Buy	+24,956	New	+$40.3K	﹤0.01%	1681
2024 Q3	–	Sell	-105,836	Closed	-$244K	–	2164
2024 Q2	$244K	Buy	+105,836	New	+$440K	﹤0.01%	1470
2024 Q1	–	Sell	-29,060	Closed	-$71.8K	–	2347
2023 Q4	$71.8K	Buy	+29,060	New	+$276K	﹤0.01%	1693
2023 Q1	–	Sell	-35,070	Closed	-$1.15M	–	2099
2022 Q4	$1.15M	Buy	+35,070	New	+$1.04M	0.06%	415

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jump Financial's VTYX Position: Q1 2026 in Review

Jump Financial sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 76,200 shares — an estimated $688K sold.

Jump Financial first reported a position in VTYX in Q4 2022 and held it in 5 quarters. The position peaked at $1.15M in Q4 2022. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Jump Financial reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Jump Financial sold 76,200 Ventyx Biosciences shares in Q1 2026, an estimated $688K.
Jump Financial first reported a position in Ventyx Biosciences in Q4 2022 and held it in 5 quarters.
Jump Financial's Ventyx Biosciences position peaked at $1.15M in Q4 2022.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.